2025-10-27T07:27:57-05:00 2024-12-31 SMITH & HOWARD ADVISORY LLC 271 17TH STREET NW SUITE 2100 ATLANTA GA 30363 990 2024-01-01 831484206 Daughters Against Alzheimer's Inc % SUSAN WATSON DAUG 4042295140 3215 WOOD VALLEY ROAD ATLANTA GA 30327 MICHELLE ROOKS TREASURER 4042295140 2025-11-15 true true SABRE J LINAHAN P01372980 4048746244 2025-11-15 2024 2025-03-06 01:10:19Z SUSAN WATSON 3215 WOOD VALLEY ROAD ATLANTA GA 30327 1367134 false X HTTPS://DAUGHTERSAGAINSTALZ.ORG/ X 2018 GA WE ARE COMMITTED TO SUPPORTING MEDICAL RESEARCH RELATED TO ALZHEIMER'S DISEASE & OTHER DEMENTIAS. 5 4 0 250 0 1167264 1055800 0 0 33 8234 -30819 34350 1136478 1098384 685000 900000 0 0 96000 107000 0 0 85700 76888 86157 857888 1093157 278590 5227 483883 647446 373323 531659 110560 115787 X IN SUPPORT OF THE NATIONAL INSTITUTE ON AGING (NIA) AND NATIONAL PLAN TO ADDRESS ALZHEIMER'S DISEASE (NAPA), DAUGHTERS AGAINST ALZHEIMER'S IS HONORED TO SUPPORT THE PLAN'S AMBITIOUS GOALS TO BOTH PREVENT FUTURE CASES OF ALZHEIMER'S AND TO MEET THE NEEDS OF THE MILLIONS OF AMERICAN FAMILIES CURRENTLY FACING THESE DISEASES. WITH THEIR STRONG COMMITMENT TO RESEARCH, DAA IS PROUD TO SUPPORT COLLABORATIVE WORK AMONG THE WORLD'S PREMIER DOCTORS, SCIENTISTS, AND RESEARCHERS AT EMORY'S GOIZUETA ALZHEIMER'S DISEASE RESEARCH CENTER. OUR FOCUS ON EARLY DIAGNOSTICS RELATING TO ALZHEIMER'S AND DEMENTIA WILL EASILY SCREEN AND HELP FACILITATE EFFECTIVE TREATMENT FOR ASYMPTOMATIC OR PRE-SYMPTOMATIC PEOPLE BEFORE COGNITIVE DECLINE BEGINS. BY WORKING TOGETHER, WE CAN CHANGE THE TRAJECTORY OF ALZHEIMER'S AND DEMENTIA FOR THE NEXT GENERATION. false false 900000 900000 IN 2024, DAUGHTERS AGAINST ALZHEIMER'S (DAA) CONTINUED TO ADVANCE ITS MISSION TO FUND CUTTING-EDGE RESEARCH FOR THE PREVENTION, TREATMENT, AND CURE OF ALZHEIMER'S DISEASE. IN ADDITION TO HOSTING OUR SIGNATURE FUNDRAISING EVENT, BATTLE FOR THE BRAIN, DAA EXPANDED ITS YEAR-ROUND FUNDRAISING EFFORTS THROUGH A SERIES OF ANCILLARY INITIATIVES. THESE INCLUDED A MOTHER'S DAY RAFFLE, A JEWELRY PERCENTAGE EVENT, AND RETAIL PARTNERSHIPS AIMED AT INCREASING BOTH AWARENESS AND FUNDS. WE WERE ALSO HONORED TO BE SELECTED AS ONE OF THE BENEFICIARIES OF THE COUNTRY CLUB OF ROSWELL'S PRO-AM CHARITY TOURNAMENT, AND CONTINUED TO BENEFIT FROM CORPORATE MATCHING GIFTS. DAA LAUNCHED A JUNIOR ADVISORY BOARD AND COMMITTEE TO HELP CULTIVATE THE NEXT GENERATION OF NONPROFIT LEADERS AND AMBASSADORS IN THE FIGHT TO #FORGETALZ. THESE COLLECTIVE EFFORTS ENABLED DAA TO PROVIDE A $900,000 GRANT TO OUR PRIMARY BENEFICIARY, EMORY'S GOIZUETA ALZHEIMER'S DISEASE RESEARCH CENTER. FINANCIAL SUPPORT FOR THE ORGANIZATION REMAINED STRONG THROUGHOUT THE YEAR, WITH SIGNIFICANT CONTRIBUTIONS MADE IN 2024 TOWARD OUR 2025 FUNDRAISING GOALS. OUR 2025 EVENT HAS ALREADY EXCEEDED EXPECTATIONS AND FURTHER SOLIDIFIED DAA'S IMPACT IN THE COMMUNITY AND BEYOND. 900000 true true false false false false false false false false false false false false true true false false false false false false false true false false true false false false false false false false false false false false false false false false false false false true 8 0 0 false false false false false true true false false false false false false X 5 4 false false false false false false false true false false true true true true true true true false false GA X SUSAN WATSON 4042295140 3215 WOOD VALLEY ROAD ATLANTA GA 30327 MICHELLE ROOKS TREASURER 50.0 0.0 X X 107000 0 0 SUSAN WATSON PRESIDENT 25.0 0.0 X X 0 0 0 CAROLINE VROON SECRETARY 2.0 0.0 X X 0 0 0 TARA BYRNE DIRECTOR 2.0 0.0 X 0 0 0 Anna Downs Director 2.0 0.0 X 0 0 0 107000 0 0 1 false false false 0 1022175 33625 1055800 0 8234 8234 0 0 0 0 0 0 303100 1022175 268750 34350 34350 0 0 0 0 0 0 0 1098384 42584 900000 900000 0 0 0 107000 53500 53500 0 0 0 0 0 0 0 23105 23105 0 0 0 15795 2590 13205 1402 1402 2507 2339 168 17006 2045 14961 0 0 0 0 0 0 0 0 950 950 CREDIT CARD FEES 20411 20411 GRANT WRITING 2040 2040 MEALS 1117 1117 WEBSITE COSTS 804 804 1020 596 424 1093157 900000 107457 85700 X 433961 600584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 49922 46862 0 0 0 0 0 0 0 0 0 0 0 0 483883 647446 3905 4397 0 0 369418 527262 0 0 0 0 0 0 0 0 0 0 0 0 373323 531659 X 110560 115787 0 0 110560 115787 483883 647446 5227 X false true X true false X 462312 83844 754667 1167264 1055800 3523887 0 0 462312 83844 754667 1167264 1055800 3523887 307428 3216459 33 8234 8267 0 0 3532154 702131 0.91062 0.85810 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 X 1171699 73315 73315 1098384 1098384 1166472 73315 73315 1093157 1093157 SCHEDULE D, PART X, LINE 2 THE ORGANIZATION IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(A) OF THE INTERNAL REVENUE CODE (THE "CODE"), AS AN ORGANIZATION DESCRIBED IN SECTION 501(C)(3) OF THE CODE OF 1986, AS AMENDED. ACCORDINGLY, THE ORGANIZATION IS EXEMPT FROM FEDERAL INCOME TAXES EXCEPT FOR ANY UNRELATED BUSINESS INCOME WHICH IS SUBJECT TO UNRELATED BUSINESS INCOME TAX. THE ORGANIZATION ANNUALLY EVALUATES ALL FEDERAL AND STATE INCOME TAX POSITIONS. THIS PROCESS INCLUDES AN ANALYSIS OF WHETHER THESE INCOME TAX POSITIONS THE ORGANIZATION TAKES MEET THE DEFINITION OF AN UNCERTAIN TAX POSITION UNDER THE INCOME TAXES TOPIC OF THE FINANCIAL ACCOUNTING STANDARDS CODIFICATION. IN THE NORMAL COURSE OF BUSINESS, THE ORGANIZATION IS SUBJECT TO EXAMINATION BY THE FEDERAL AND STATE TAXING AUTHORITIES. IN GENERAL, THE ORGANIZATION IS NO LONGER SUBJECT TO TAX EXAMINATIONS FOR THE TAX YEARS ENDING BEFORE DECEMBER 31, 2021. SCHEDULE D, PART XI, LINE 2D FUNDRAISING EVENT EXPENSES: $73,315 SCHEDULE D, PART XII, LINE 2D FUNDRAISING EVENT EXPENSES: $73,315 BATTLE FOR BRAI 1325275 1022175 303100 52830 138944 56491 20485 0 1325275 1022175 303100 52830 138944 56491 20485 268750 34350 true EMORY UNIVERSITY 1762 Clifton Road Suite 1400 ATLANTA GA 30322 582566256 501(C)(3) 900000 RESEARCH 1 SCHEDULE I, PART II, LINE 1 Battle for the Brain proceeds are donated to Emory's Goizueta Alzheimer's Disease Research Center and support unrestricted research relating to digital and traditional biomarkers so that we can detect and treat Alzheimer's and dementia in their earliest stages. FORM 990, PART VI, SECTION A, LINE 8B DUE TO THE SIZE OF THE BOARD, SEPARATE COMMITTEES ARE NOT NECESSARY. AS SUCH, QUESTION 8B OF PART VI IS NOT APPLICABLE. FORM 990, PART VI, SECTION B, LINE 11 FORM 990 IS PREPARED BY AN INDEPENDENT CPA FIRM. THE BOARD REVIEWS THE FORM 990 AND THE UNDERLYING FINANCIALS PRIOR TO THE SUBMISSION OF THE FORM 990 TO THE IRS. FORM 990, PART VI, SECTION B, LINE 12C BOARD MEMBERS HAVE THE OPPORTUNITY TO DISCUSS WHETHER A NEW CONFLICT OF INTEREST HAS RISEN AT EACH BOARD MEETING. FORM 990, PART VI, SECTION B, LINE 15a THE DAUGHTERS AGAINST ALZHEIMER'S (DAA) BOARD OF DIRECTORS CONDUCTS AN APPROPRIATE REVIEW OF COMPARABLE COMPENSATION LEVELS TO DETERMINE THE COMPENSATION LEVEL FOR THE SERVICE OF ONE OF THE CO-FOUNDERS, WHO SERVES AS EXECUTIVE DIRECTOR OF THE ORGANIZATION. THE REVIEW AND SURVEY INCLUDE THE FOLLOWING ELEMENTS: SURVEY OF CEO COMPENSATION FOR COMPARABLE CHARITIES, SURVEY OF NONPROFIT CEO COMPENSATION IN THE ATLANTA MARKET FOR SIMILAR ORGANIZATIONS, SIMILAR BUDGETS, AND SIMILAR STAFF, AND THE EXECUTIVE COMMITTEE RECOMMENDS A COMPENSATION LEVEL THAT IS APPROVED BY THE BOARD. DURING PERIODIC REVIEWS THE BOARD OF DIRECTORS WILL DETERMINE WHETHER COMPENSATION ARRANGEMENTS AND BENEFITS ARE REASONABLE, BASED ON COMPETENT SURVEY INFORMATION, MARKET CONDITIONS, AND THE RESULT OF ARM'S LENGTH BARGAINING. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, ETC. ARE MADE AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST.